Olympiad Research’s Compass Minerals CMP Stock Holding History

Olympiad Research’s Portfolio CMP Stock Details CMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,144	Closed	-$246K	–	265
2021 Q2	$246K	Buy	+4,144	New	+$275K	0.09%	198
2020 Q4	–	Sell	-6,663	Closed	-$395K	–	164
2020 Q3	$395K	Buy	+6,663	New	+$367K	0.2%	108

Other funds holding CMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $209M AUM 9.57% 1-Year Est. Return

Olympiad Research's CMP Position: Q3 2021 in Review

Olympiad Research sold out of Compass Minerals (CMP) in Q3 2021, closing a stake of 4,144 shares — an estimated $246K sold.

Olympiad Research first reported a position in CMP in Q3 2020 and held it in 2 quarters. The position peaked at $395K in Q3 2020. 295 funds tracked by Wall St. Rank hold CMP as of Q3 2021.

Olympiad Research reported no remaining Compass Minerals position as of Q3 2021 after selling out during the quarter.
Olympiad Research sold 4,144 Compass Minerals shares in Q3 2021, an estimated $246K.
Olympiad Research first reported a position in Compass Minerals in Q3 2020 and held it in 2 quarters.
Olympiad Research's Compass Minerals position peaked at $395K in Q3 2020.
295 funds tracked by Wall St. Rank held Compass Minerals as of Q3 2021.

Based on Olympiad Research's 13F filing for Q3 2021, filed 9 Nov 2021.